Press Releases

The two former Max Planck researchers have been honoured for their discovery of light-sensitive ion channels. The Max Planck Institute of Biochemistry is delighted that Peter Hegemann’s work, carried out at our institute in Martinsried in the 1980s and 1990s, has been awarded with this year’s Nobel Prize in Physiology or Medicine.

F.-Ulrich Hartl, director at the Max Planck Institute of Biochemistry, is receiving this year’s “Keio Medical Science Prize” for his work in elucidating the mechanisms of protein folding mediated by molecular chaperones and beyond.

Scientists led by Jürg Müller at the MPI of Biochemistry reveal the molecular architecture of the gene-silencing complex PRC1 and how it is targeted to genes controlling cell identity.

Brenda Schulman, director at the Max Planck Institute of Biochemistry, has been elected Foreign Member of the Royal Society in London, United Kingdom.

Matthias Mann, director at the Max Planck Institute of Biochemistry in Martinsried, Germany has received two research grants to study the mechanisms of Parkinson's disease from Aligning Science Across Parkinson's in partnership with The Michael J. Fox Foundation for Parkinson’s Research.

The international Cytokine and Interferon Society honors the independent group leader of the Max Planck Institute of Biochemistry with the William E. Paul Award 2026 for Excellence in Cytokine Research.

A new pan-European postdoctoral programme to support research and innovation in bottom-up synthetic biology through high-level interdisciplinary training.

Show more
Go to Editor View